Hazardous Drug List

National Institutes of Health Clinical Center

HAZARDOUS DRUG LIST

P&T Approved: March 28, 2019

Background

This list defines drugs that both the National Institute for Occupational Safety and Health (NIOSH) as well as the NIH Clinical Center

(based on an internal hazard safety assessment) considers hazardous and require extra safety precautions for handling, preparation,

and administration in the health care setting. These precautions may vary with drug formulation/dosage form and route of

administration.

NIOSH categorizes hazardous drugs into 3 groups:

Group 1

Antineoplastic medications

Group 2

Non-antineoplastic drugs that meet one or more NIOSH criteria for a hazardous drug (Note: some of these drugs may also

pose a reproductive risk for susceptible populations)

Group 3

Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are

pregnant or breastfeeding

Acronyms

 CSTD = closed system drug-transfer device

 PPE = personal protective equipment

Citation

NIOSH [2016]. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. By Connor TH, MacKenzie BA, DeBord DG,

Trout DB, O’Callaghan JP. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National

Institute for Occupational Safety and Health, DHHS (NIOSH) Publication Number 2016-161 (Supersedes 2014-138).

Page 1 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

abacavir

Ziagen

Oral tablet

F

2

Single chemotherapy gloves

abacavir

Ziagen

Oral solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

abacavir/lamivudine

Epzicom

Oral tablet

F

2

Single chemotherapy gloves

abacavir/dolutegravir/lamivudine

Triumeq

Oral tablet

F

2

Single chemotherapy gloves

abacavir/lamivudine/zidovudine

Trizivir

Oral tablet

NF

2

Single chemotherapy gloves

abiraterone acetate

Zytiga

Oral tablet

NF

1

Single chemotherapy gloves

acitretin

Soriatane

Oral capsule

NF

3

Single chemotherapy gloves

ado-trastuzumab emtansine

Kadcyla

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

afatinib

Gilotrif

Oral tablet

NF

1

Single chemotherapy gloves

alitretinoin

Panretin

Topical gel/jelly

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

ambrisentan

Letairis

Oral tablet

F

3

Single chemotherapy gloves

anastrozole

Arimidex

Oral tablet

F

1

Single chemotherapy gloves

apomorphine

Apokyn

Subcutaneous solution

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

arsenic trioxide

Trisenox

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

axitinib

Inlyta

Oral tablet

NF

1

Single chemotherapy gloves

azaCITIDine

Vidaza

Suspension for injection

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

azaTHIOprine

Imuran; Azasan

Oral tablet

F

2

Single chemotherapy gloves

azaTHIOprine

N/A

Intravenous solution

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 2 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

Bacillus Calmette Guerin (BCG)

vaccine

Tice BCG

Percutaneous powder for solution;

intravesical powder for suspension

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

belinostat

Beleodaq

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

bendamustine

Treanda, Bendeka

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

bevacizumab

Avastin

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

bexarotene

Targretin

Oral capsule

NF

1

Single chemotherapy gloves

bexarotene

Targretin

Topical gel/jelly

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

bicalutamide

Casodex

Oral tablet

F

1

Single chemotherapy gloves

bleomycin

Blenoxane

Solution for injection

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

blinatumomab

Blincyto

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

bortezomib

Velcade

Solution for injection

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

bosentan

Tracleer

Oral tablet

F

3

Single chemotherapy gloves

bosentan

Tracleer

Oral tablet for suspension

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

bosutinib

Bosulif

Oral tablet

NF

1

Single chemotherapy gloves

Page 3 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

botulinum toxins, all forms

Dysport, Xeomin, Botox,

Myobloc

Intramuscular injection

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

brentuximab vedotin

Adcetris

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

brigatinib

Alunbrig

Oral tablet

NF

N/A

Single chemotherapy gloves

busulfan

Myleran

Oral tablet

F

1

Single chemotherapy gloves

busulfan

Busulfex

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

cabazitaxel

Jevtana

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

cabergoline

N/A

Oral tablet

F

3

Single chemotherapy gloves

cabozantinib

Cabometyx; Cometriq

Oral tablet; oral capsule

NF

1

Single chemotherapy gloves

capecitabine

Xeloda

Oral tablet

F

1

Single chemotherapy gloves

carBAMazepine

Carbatrol, Equetro, Epitol,

Tegretol

Oral tablet; oral capsule

F

2

Single chemotherapy gloves

carBAMazepine

Tegretol

Oral suspension

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

CARBOplatin

Paraplatin

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

carfilzomib

Kyprolis

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

carmustine

BiCNU; Gliadel Wafer

Intravenous solution; implant wafer

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

ceritinib

Zykadia

Oral capsule

NF

1

 Single chemotherapy gloves

Page 4 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

cetrorelix

Cetrotide

Subcutaneous solution

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

chlorambucil

Leukeran

Oral tablet

F

1

Single chemotherapy gloves

chloramphenicol

Chloromycetin

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

chorionic gonadotropin, human

Novarel, Pregnyl

Intramuscular solution for injection

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

chorionic gonadotropin,

recombinant

Ovidrel

Subcutaneous solution for injection

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

cidofovir

Vistide

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

CISplatin

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

cladribine

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

cloBAZam

Onfi

Oral tablet

F

3

 Single chemotherapy gloves

cloBAZam

Onfi

Oral suspension

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

clofarabine

Clolar

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

clomiPHENE

N/A

Oral tablet

F

3

Single chemotherapy gloves

clonazePAM

KlonoPIN

Oral tablet

F

3

Single chemotherapy gloves

cobimetinib

Cotellic

Oral tablet

NF

1

Single chemotherapy gloves

colchicine

Colcrys; Mitigare

Oral tablet; oral capsule

F

3

Single chemotherapy gloves

Page 5 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

crizotinib

Xalkori

Oral capsule

NF

1

Single chemotherapy gloves

cyclophosphamide

N/A

Oral capsule; oral tablet

F

1

Single chemotherapy gloves

cyclophosphamide

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

cycloSPORINE

Gengraf, Neoral, Sandimmune

Oral capsule

F

2

Single chemotherapy gloves

cycloSPORINE

Gengraf, Neoral, Sandimmune

Oral solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

cycloSPORINE

Sandimmune

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

cycloSPORINE

Restasis

Ophthalmic emulsion

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

cytarabine (conventional)

N/A

Injection solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

dabrafenib

Tafinlar

Oral capsule

NF

1

Single chemotherapy gloves

dacarbazine

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

DACTINomycin

Cosmegen

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

darbepoetin alfa

Aranesp

Intravenous/subcutaneous solution for

injection

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

dasatinib

Sprycel

Oral tablet

F

1

Single chemotherapy gloves

DAUNOrubicin (conventional)

Cerubidine

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 6 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

decitabine

Dacogen

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

deferiprone

Ferriprox

Oral tablet

NF

2

Single chemotherapy gloves

deferiprone

Ferriprox

Oral solution

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

degarelix

Firmagon

Subcutaneous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

desflurane

Suprane

Solution for inhalation

NF

N/A

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

dexrazoxane

Zinecard

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

dihydroergotamine

D.H.E. 45

Solution for injection (IV, IM, SC)

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

dihydroergotamine

Migranal

Nasal spray

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

dinoprostone

Cervidil; Prepidil; Prostin E2

Vaginal insert; vaginal gel/jelly; vaginal

suppository

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

divalproex

Depakote; Depakote ER;

Depakote Sprinkles; Depakote

DR

Oral tablet; oral capsule

F

2

Single chemotherapy gloves

Page 7 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

DOCEtaxel

Taxotere

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

DOXOrubicin (conventional)

Adriamycin

Intravenous solution;

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

DOXOrubicin (liposomal)

Doxil

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

dronedarone

Multaq

Oral tablet

F

3

Single chemotherapy gloves

dutasteride

Avodart

Oral capsule

NF

3

Single chemotherapy gloves

enasidenib

IDHIFA

Oral tablet

NF

N/A

Single chemotherapy gloves

entecavir

Baraclude

Oral tablet

F

2

Single chemotherapy gloves

entecavir

Baraclude

Oral solution

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

enzalutamide

Xtandi

Oral capsule

F

1

Single chemotherapy gloves

epiRUBicin

Ellence

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

eriBULin mesylate

Halaven

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

erlotinib

Tarceva

Oral tablet

F

1

Single chemotherapy gloves

eslicarbazepine acetate

Aptiom

Oral tablet

F

3

Single chemotherapy gloves

estradiol

many branded & generic

products such as Estring;

EstroGel; Evamist

Oral tablet

F

2

Single chemotherapy gloves

estradiol

many branded & generic

products such as Estring,

Vagifem

Vaginal tablet; vaginal cream; vaginal insert

ring; transdermal patch; transdermal gel/jelly;

topical gel/jelly; transdermal spray

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

estradiol/norethindrone

CombiPatch

Transdermal patch

F

2

 Double chemotherapy gloves

 Protective gown

estramustine

Emcyt

Oral capsule

F

1

Single chemotherapy gloves

Page 8 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

estrogen; conjugated

Premarin

Oral tablet

F

2

Single chemotherapy gloves

estrogen; conjugated

Premarin

Vaginal cream

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

estrogen; conjugated

Premarin

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

estrogen (esterified)

Menest

Oral tablet

NF

2

Single chemotherapy gloves

estrogen (conjugated) and

medroxyprogesterone

Prempro

Oral tablet

F

2

Single chemotherapy gloves

estropipate

Ogen .625; Ogen 1.25; Ogen

2.5; Ortho-Est

Oral tablet

NF

2

Single chemotherapy gloves

ethinyl estradiol/ethynodiol

diacetate

Zovia; Kelnor

Oral tablet

F

2

Single chemotherapy gloves

ethinyl estradiol/levonorgestrel

Enpresse; Jolessa

Oral tablet

F

2

Single chemotherapy gloves

ethinyl estradiol/norelgestromin

Xulane

Transdermal patch

F

2

 Double chemotherapy gloves

 Protective gown

ethinyl estradiol/norethindrone

Loestrin FE; Migrogestin FE

Oral tablet

F

2

Single chemotherapy gloves

ethinyl estradiol/norgestrel

Low-Ogestrel

Oral tablet

F

2

Single chemotherapy gloves

etonogestrel

Nexplanon

Subcutaneous Implant

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

etoposide

N/A

Oral capsule

F

1

Single chemotherapy gloves

etoposide

Toposar

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

etoposide phosphate

Etopophos

Intravenous solution

NF

N/A

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

everolimus

Afinitor; Zortress

Oral tablet

NF

1

Single chemotherapy gloves

everolimus

Afinitor; Zortress

Oral tablet for suspension

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

exemestane

Aromasin

Oral tablet

NF

1

Single chemotherapy gloves

Page 9 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

exenatide

Byetta, Bydureon

Subcutaneous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

finasteride

Propecia; Proscar

Oral tablet

NF

3

Single chemotherapy gloves

fingolimod

Gilenya

Oral capsule

NF

2

Single chemotherapy gloves

floxuridine

N/A

Solution for injection

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

fluconazole

Diflucan

Oral tablet

F

3

Single chemotherapy gloves

fluconazole

Diflucan

Oral suspension

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

fluconazole

Diflucan

Intravenous solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

flucytosine

Ancobon

Oral capsule

F

N/A

Single chemotherapy gloves

fludarabine

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

fluorouracil

Adrucil

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

fluorouracil

Carac, Efudex, Fluoroplex,

Tolak

Topical cream; topical solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

flutamide

N/A

Oral capsule

F

1

Single chemotherapy gloves

fosphenytoin

Cerebyx

Injection solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

fulvestrant

Faslodex

Intramuscular solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 10 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

ganciclovir

Cytovene

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

ganciclovir

Zirgan

Ophthalmic gel/jelly

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

ganirelix

N/A

Subcutaneous solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

gemcitabine

Gemzar

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

gemtuzumab ozogamicin

Mylotarg

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

goserelin

Zoladex

Subcutaneous implant

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

histrelin

Supprelin LA, Vantas

Subcutaneous implant

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

hydroxyurea

Droxia; Hydrea

Oral capsule

F

1

Single chemotherapy gloves

icatibant

Firazyr

Subcutaneous solution

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

IDArubicin

Idamycin PFS

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

ifosfamide

Ifex

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 11 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

imatinib

Gleevec

Oral tablet

F

1

Single chemotherapy gloves

inotuzumab ozogamicin

Besponsa

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

interferon beta-1b

Betaseron, Extavia

Subcutaneous injection

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

irinotecan (conventional)

Camptosar

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

irinotecan (liposomal)

Onivyde

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

isoflurane

Forane, Terrell

Solution for inhalation

NF

N/A

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

ISOtretinoin

Absorica, Amnesteem,

Claravis, Myorisan, Zenatane

Oral capsule

F

3

Single chemotherapy gloves

ivabradine

Corlanor

Oral tablet

F

3

Single chemotherapy gloves

ixabepilone

Ixempra Kit

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

ixazomib

Ninlaro

Oral capsule

NF

1

Single chemotherapy gloves

lapatinib

Tykerb

Oral tablet

NF

N/A

Single chemotherapy gloves

leflunomide

Arava

Oral tablet

F

2

Single chemotherapy gloves

lenalidomide

Revlimid

Oral capsule

F

2

Single chemotherapy gloves

lenvatinib

Lenvima

Oral capsule

NF

1

Single chemotherapy gloves

letrozole

Femara

Oral tablet

F

1

Single chemotherapy gloves

leuprolide

Lupron, Lupron Depot

Subcutaneous suspension; intramuscular

suspension

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

levonorgestrel

Aftera, EContra, Plan B

Oral tablet

F

2

Single chemotherapy gloves

levonorgestrel

Mirena

Intrauterine device

F

2

 Double chemotherapy gloves

 Protective gown

Page 12 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

lomitapide

Juxtapid

Oral capsule

NF

3

Single chemotherapy gloves

lomustine

Gleostine

Oral capsule

NF

1

Single chemotherapy gloves

macitentan

Opsumit

Oral tablet

NF

3

Single chemotherapy gloves

mechlorethamine

Mustargen

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

mechlorethamine

Valchlor

Topical gel

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

medroxyPROGESTERone

Provera

Oral tablet

F

2

Single chemotherapy gloves

medroxyPROGESTERone

Depo-Provera

Intramuscular suspension

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

megestrol

Megace

Oral tablet

F

1

Single chemotherapy gloves

megestrol

Megace

Oral suspension

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

melphalan

Alkeran

Oral tablet

F

1

Single chemotherapy gloves

melphalan

Alkeran; Evomela

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

menotropins

Menopur

Subcutaneous solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

mercaptopurine

Purinethol

Oral tablet

F

1

Single chemotherapy gloves

mercaptopurine

Purixan

Oral suspension

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

methIMAzole

Tapazole

Oral tablet

F

2

Single chemotherapy gloves

methotrexate

Trexall

Oral tablet

F

1

Single chemotherapy gloves

methotrexate

Xatmep

Oral solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

Page 13 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

methotrexate

N/A

Solution for injection

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

methotrexate

Otrexup, Rasuvo

Subcutaneous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

methoxsalen

Oxsoralen Ultra

Oral capsule

NF

N/A

Single chemotherapy gloves

methoxsalen

Uvadex

Solution for injection

F

N/A

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

methylergonovine

Methergine

Oral tablet

F

3

Single chemotherapy gloves

methylergonovine

N/A

Solution for injection

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

methylTESTOSTERone

Methitest

Oral tablet; oral capsule

NF

3

Single chemotherapy gloves

midostaurin

Rydapt

Oral capsule

F

N/A

Single chemotherapy gloves

miFEPRIStone

Korlym; Mifeprex

Oral tablet

NF

3

Single chemotherapy gloves

Miltefosine

Impavido

Oral capsule

NF

3

Single chemotherapy gloves

mipomersen

Kynamro

Subcutaneous solution

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

miSOPROStol

Cytotec

Oral tablet

NF

3

Single chemotherapy gloves

mitoMYcin

Mutamycin

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

mitotane

Lysodren

Oral tablet

F

1

Single chemotherapy gloves

mitoXANTRONE

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

mycophenolate mofetil

CellCept

Oral tablet; oral capsule

F

2

Single chemotherapy gloves

mycophenolate mofetil

CellCept

Oral suspension

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

Page 14 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

mycophenolate mofetil

CellCept

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

mycophenolic acid

Myfortic

Oral tablet

NF

2

Single chemotherapy gloves

nafarelin

Synarel

Nasal spray

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

nelarabine

Arranon

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

nevirapine

Viramune

Oral tablet

F

2

Single chemotherapy gloves

nevirapine

Viramune

Oral suspension

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

nilotinib

Tasigna

Oral capsule

F

1

Single chemotherapy gloves

norethindrone

Camila; Ortho Micronor

Oral tablet

F

2

Single chemotherapy gloves

olaparib

Lynparza

Oral capsule; oral tablet

NF

1

Single chemotherapy gloves

omacetaxine

Synribo

Subcutaneous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

osimertinib

Tagrisso

Oral tablet

NF

1

Single chemotherapy gloves

ospemifene

Osphena

Oral tablet

NF

2

Single chemotherapy gloves

oxaliplatin

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

OXcarbazepine

Trileptal

Oral tablet

F

2

Single chemotherapy gloves

OXcarbazepine

Trileptal

Oral suspension

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

oxytocin

Pitocin

Solution for injection

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 15 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

PACLitaxel (conventional)

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

PACLitaxel (protein bound)

Abraxane

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

palifermin

Kepivance

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

pamidronate

N/A

Intravenous solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

panobinostat

Farydak

Oral capsule

NF

1

Single chemotherapy gloves

PARoxetine

Brisdelle; Paxil; Paxil CR;

Pexeva

Oral tablet; oral capsule

F

3

Single chemotherapy gloves

PARoxetine

Paxil

Oral suspension

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

pasireotide

Signifor; Signifor LAR

Intramuscular suspension; subcutaneous

solution

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

PAZOPanib

Votrient

Oral tablet

NF

1

Single chemotherapy gloves

PEMEtrexed

Alimta

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

pentamidine

Pentam

Solution for injection; solution for inhalation

F

N/A

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required (if intravenous)

 Respiratory protection (if inhalation)

pentetate calcium trisodium

diethylene triamine penta-

acetic acid

Intravenous solution

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 16 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

pentostatin

Nipent

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

pertuzumab

Perjeta

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

phenoxybenzamine

Dibenzyline

Oral capsule

F

2

Single chemotherapy gloves

phenytoin

Dilantin; Dilantin Infatabs

Oral tablet, oral capsule

F

2

Single chemotherapy gloves

phenytoin

Dilantin

Oral suspension

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

phenytoin

N/A

Injection solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

plerixafor

Mozobil

Subcutaneous solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

pomalidomide

Pomalyst

Oral capsule

NF

1

Single chemotherapy gloves

PONATinib

Iclusig

Oral tablet

NF

1

Single chemotherapy gloves

porfimer

Photofrin

Intravenous solution

NF

N/A

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

PRALAtrexate

Folotyn

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

procarbazine

Matulane

Oral capsule

NF

1

Single chemotherapy gloves

progesterone

Prometrium

Oral capsule

F

2

Single chemotherapy gloves

progesterone

N/A

Intramuscular oil

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 17 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

progesterone

Crinone; Endometrin

Vaginal gel; vaginal insert

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

propylthiouracil

N/A

Oral tablet

F

2

Single chemotherapy gloves

raloxifene

Evista

Oral tablet

NF

2

Single chemotherapy gloves

rasagiline

Azilect

Oral tablet

F

2

Single chemotherapy gloves

regorafenib

Stivarga

Oral tablet

NF

1

Single chemotherapy gloves

ribavirin

Rebetol; Ribasphere,

Moderiba

Oral capsule, oral tablet

F

3

Single chemotherapy gloves

ribavirin

Virazole

Solution for inhalation

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

riociguat

Adempas

Oral tablet

NF

3

Single chemotherapy gloves

romiDEPsin

Istodax

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

sevoflurane

Ultane

Solution for inhalation

F

N/A

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

sirolimus

Rapamune

Oral tablet

F

2

Single chemotherapy gloves

sirolimus

Rapamune

Oral solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

sonidegib

Odomzo

Oral capsule

NF

1

Single chemotherapy gloves

SORAfenib

Nexavar

Oral tablet

F

1

Single chemotherapy gloves

spironolactone

Aldactone

Oral tablet

F

2

Single chemotherapy gloves

spironolactone

CaroSpir

Oral suspension

NF

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

streptozocin

Zanosar

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 18 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

SUNItinib

Sutent

Oral capsule

F

1

Single chemotherapy gloves

tacrolimus

Prograf

Oral capsule

F

2

Single chemotherapy gloves

tacrolimus

Prograf

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

tacrolimus

Protopic

Topical ointment

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

tamoxifen

N/A

Oral tablet

F

1

Single chemotherapy gloves

tamoxifen

Soltamox

Oral solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

temazepam

Restoril

Oral capsule

F

3

Single chemotherapy gloves

temozolomide

Temodar

Oral capsule

F

1

Single chemotherapy gloves

temozolomide

Temodar

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

temsirolimus

Torisel

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

teniposide

N/A

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

teriflunomide

Aubagio

Oral tablet

NF

2

Single chemotherapy gloves

testosterone

Striant

Buccal film

NF

3

 Double chemotherapy gloves

 Protective gown

testosterone

Aveed; Depo-Testosterone

Intramuscular injection

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

testosterone

Natesto

Nasal gel

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

Page 19 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

testosterone

AndroGel; AndroGel Pump;

Testim; Fortesta; Vogelxo

Topical gel

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

testosterone

Androderm

Transdermal patch

F

3

 Double chemotherapy gloves

 Protective gown

testosterone

Testopel

Subcutaneous implant

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

thalidomide

Thalomid

Oral capsule

F

2

Single chemotherapy gloves

thioguanine

Tabloid

Oral tablet

F

1

Single chemotherapy gloves

thiotepa

Tepadina

Solution for injection

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

tofacitinib

Xeljanz; Xeljanz XR

Oral tablet

F

2

Single chemotherapy gloves

topiramate

Qudexy XR; Topamax;

Topamax Sprinkle; Trokendi

XR

Oral tablet; oral capsule

F

3

Single chemotherapy gloves

topotecan

Hycamtin

Oral capsule

NF

1

Single chemotherapy gloves

topotecan

Hycamtin

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

toremifene

Fareston

Oral tablet

NF

1

Single chemotherapy gloves

trabectedin

Yondelis

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

trametinib

Mekinist

Oral tablet

NF

1

Single chemotherapy gloves

trastuzumab

Herceptin

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

tretinoin

N/A

Oral capsule

F

3

Single chemotherapy gloves

tretinoin

Retin-A, Avita, Refissa,

Renova

Topical cream; topical gel

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 Respiratory protection if inhalation

possible

Page 20 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

triazolam

Halcion

Oral tablet

F

3

Single chemotherapy gloves

trifluridine + tipiracil

Lonsurf

Oral tablet

NF

1

Single chemotherapy gloves

triptorelin

Trelstar Mixject; Triptodur

Intramuscular suspension

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

ulipristal acetate

Ella

Oral tablet

NF

3

Single chemotherapy gloves

urofollitropin

Bravelle

Solution for injection

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

valGANciclovir

Valcyte

Oral tablet

F

2

Single chemotherapy gloves

valGANciclovir

Valcyte

Oral solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

valproate sodium / valproic acid

Depakene; Depakote;

Depakote Sprinkles

Oral capsule, oral tablet

F

3

Single chemotherapy gloves

valproate sodium / valproic acid

Depakene

Oral solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

valproate sodium / valproic acid

Depacon

Intravenous solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

valrubicin

Valstar

Intravesical solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

vandetanib

Caprelsa

Oral tablet

NF

1

Single chemotherapy gloves

vemurafenib

Zelboraf

Oral tablet

NF

1

Single chemotherapy gloves

venetoclax

Venclexta

Oral tablet

F

1

Single chemotherapy gloves

verteporfin

Visudyne

Intravenous solution

F

N/A

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

vigabatrin

Sabril

Oral tablet

NF

3

Single chemotherapy gloves

Page 21 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

vigabatrin

Sabril; Vigadrone

Oral solution

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

vinBLAStine

N/A

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

vinCRIStine

Vincasar PFS

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

vinorelbine

Navelbine

Intravenous solution

F

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

vismodegib

Erivedge

Oral capsule

NF

1

Single chemotherapy gloves

voriconazole

Vfend

Oral tablet

F

3

Single chemotherapy gloves

voriconazole

Vfend

Oral suspension

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

voriconazole

Vfend IV

Intravenous solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

vorinostat

Zolinza

Oral capsule

NF

1

Single chemotherapy gloves

warfarin

Coumadin; Jantoven

Oral tablet

F

3

Single chemotherapy gloves

zidovudine

Retrovir

Oral tablet; oral capsule

F

2

Single chemotherapy gloves

zidovudine

Retrovir

Oral syrup

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if there is potential

for patient vomiting or spitting up

zidovudine

Retrovir

Intravenous solution

F

2

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

ziprasidone

Geodon

Oral capsule

F

3

Single chemotherapy gloves

ziprasidone

Geodon

Intramuscular injection

NF

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

Page 22 of 23

National Institutes of Health Clinical Center P&T Approved: March 28, 2019

HAZARDOUS DRUG LIST

Generic names

Brand names/Synonyms

Route and Dosage Forms

Formulary

Status

NIOSH

Group

PPE For Administration

ziv-aflibercept

Zaltrap

Intravenous solution

NF

1

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

zoledronic acid

Reclast; Zometa

Intravenous solution

F

3

 Double chemotherapy gloves

 Protective gown

 Eye/face protection if splash possible

 CSTD required

zonisamide

Zonegran

Oral capsule

F

3

Single chemotherapy gloves

Page 23 of 23